Patents by Inventor Tarun Patel

Tarun Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150081497
    Abstract: A system for managing a real estate and/or business transaction between a buyer and a seller from receiving information from the seller regarding a commercial property, or other asset, to be sold, to closing, is provided. The system may be configured to generate a valuation of the commercial property and/or asset to be sold for the buyer and/or the seller, to populate and generate documents related to the transaction, to enable the buyer and the seller to accept or reject documents related to the transaction, and to gather relevant documents, invoices, and property data to send to an escrow agency.
    Type: Application
    Filed: March 18, 2014
    Publication date: March 19, 2015
    Inventors: Tarun Patel, Khanderao Kand, Davinder Pal Gulati, Mukesh J. Mowji
  • Publication number: 20130064870
    Abstract: The dry powder inhalation composition comprising (1) salmeterol xinafoate having mean particle size in range of 2.0?-6? microns and a tapped density in the range of 0.20 g·cm?3 to 0.45 g·cm?3 and (2) optionally, one or more other active ingredients and pharmaceutically acceptable carrier.
    Type: Application
    Filed: May 13, 2011
    Publication date: March 14, 2013
    Applicant: SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED
    Inventors: Subhas Bhowmick, Prashant Kane, Ganesh S, Tarun Patel, Swapnil Chudiwal
  • Publication number: 20070123593
    Abstract: The invention relates to a composition for the treatment of a cyclooxygenase-2-mediated disorder or condition comprising 5-methyl-2-(2?-chloro-6?-fluoroanilino)phenylacetic acid or a pharmaceutically acceptable salt, preferably the potassium salt, thereof suitable for parenteral administration, and to a method for the treatment of a cyclooxygenase-2-mediated disorder or condition in a human or animal in need of such treatment by parenteral administration of 5-methyl-2-(2?-chloro-6?-fluroanilino)phenylacetic acid or a pharmaceutically acceptable salt, preferably the potassium salt, thereof.
    Type: Application
    Filed: October 7, 2004
    Publication date: May 31, 2007
    Inventors: Rose-Marie Dannenfelser, Vivian Georgousis, Maha Khaled, Tarun Patel, Joseph Sikora, Barbara Wang